RedHill Biopharma (RDHL) Enterprise Value (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Enterprise Value of -$4.6 million for Q4 2025, little changed year-over-year from -$4.6 million in Q4 2024, and little changed quarter-over-quarter from -$4.6 million in Q2 2025.
RedHill Biopharma (RDHL) Enterprise Value (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Enterprise Value for 15 consecutive years, with -$4.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value changed 0.0% year-over-year to -$4.6 million; the TTM figure through Dec 2025 stood at -$4.6 million (changed 0.0% YoY), while the FY2025 annual figure was -$4.6 million, up 17.09% from the prior year.
- Enterprise Value steadied at -$4.6 million in Q4 2025 per RDHL's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.6 million in Q4 2024 and bottomed at -$76.4 million in Q1 2021.
- Historically, Enterprise Value has averaged -$28.1 million across 5 years, with a median of -$20.0 million in 2022.
- Annual changes were most pronounced in 2021 — Enterprise Value tumbled 49.2% — and 2024, when it jumped 76.88%.
- RedHill Biopharma's Enterprise Value stood at -$29.9 million in 2021, then surged by 33.33% to -$20.0 million in 2022, then changed by 0.0% to -$20.0 million in 2023, then surged by 76.88% to -$4.6 million in 2024, then changed by 0.0% to -$4.6 million in 2025.
- Business Quant data shows RDHL's Enterprise Value at -$4.6 million in Q4 2025, -$4.6 million in Q2 2025, and -$4.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | -4.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.62 Mn |
| Jun 30, 2025 | -4.62 Mn |
| Dec 31, 2024 | -4.62 Mn |
| Jun 30, 2024 | -7.28 Mn |
| Dec 31, 2023 | -19.97 Mn |
| Jun 30, 2023 | -19.97 Mn |
| Mar 31, 2023 | -17.57 Mn |
| Dec 31, 2022 | -19.97 Mn |
| Sep 30, 2022 | -29.47 Mn |
| Jun 30, 2022 | -29.47 Mn |
| Mar 31, 2022 | -29.47 Mn |
| Dec 31, 2021 | -29.95 Mn |
| Sep 30, 2021 | -52.29 Mn |
| Jun 30, 2021 | -76.45 Mn |
| Mar 31, 2021 | -76.45 Mn |
| Dec 31, 2020 | -37.22 Mn |
| Sep 30, 2020 | -35.05 Mn |
| Jun 30, 2020 | -86.13 Mn |
| Mar 31, 2020 | -87.81 Mn |
| Dec 31, 2019 | -40.78 Mn |